To ameliorate atopic dermatitis, it inhibits the Akt, Nuclear Factor kappa light-chain-enhancer of activated B cells (NF-κB), and Signal Transducer and Activator of Transcription 1 (STAT1) signaling pathways (Kang et al. 2021). The gene discussed is STAT1; the disease is atopic eczema.